Newsletter | January 11, 2025

01.11.25 -- Life Science Leader Best Of December

DECEMBER'S BEST FEATURED EDITORIAL

The Fork In The Road: Personal Decisions That Change Our Career Trajectory

Novo Nordisk SVP Blandine Lacroix shares her career story and discusses the importance of prioritizing your own personal needs, and the personal needs of others, in navigating a professional career.

What Will The Incoming Trump Administration Mean For Drug Patents?

Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions about what a second Trump administration could mean for biopharmaceutical IP and drug patents.

Where Are They Now? Teva Pharmaceuticals

Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, and branded drugs to set the company back on track, or back to the future.

DECEMBER'S BEST INDUSTRY INSIGHTS

Perspectives On Performance, Scalability, And Regulatory Compliance

Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.

North Carolina: A Rising Hub For Radiopharmaceutical Innovation

Radiopharmaceuticals are on the brink of transforming cancer treatment and diagnostics. Learn more about how North Carolina has become the epicenter of this radioactive drug revolution.

Breaking The Mold: How R Is Revolutionizing CSR Generation

The open-source statistical programming language R is becoming more popular in the life sciences sector for clinical study report submissions due to its cost-effectiveness, inclusivity, and collaboration.